InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by BAILEY DON M. Director active across 1 company, notably Lineage Cell Therapeutics, Inc.. Aggregated, 1 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €93k. History available since 8 February 2024. The latest transaction was filed on 8 February 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration